Can using a CPAP lower mortality risk from sleep apnea–related heart disease?

Continuous Positive Airway Pressure (CPAP) is a standard treatment for obstructive sleep apnea (OSA). In this episode, we explain how untreated OSA affects cardiovascular health and what current evidence suggests about CPAP and long-term heart risk in Europe.

You’ll learn:

• What obstructive sleep apnea is: repeated airway collapse during sleep causing oxygen drops

• How OSA increases risk of hypertension, arrhythmia, stroke, and coronary artery disease

• How CPAP works to maintain airway patency and improve oxygenation overnight

• What studies suggest about CPAP use and reduced cardiovascular complications

• The importance of sleep studies, diagnostic criteria (AHI score), and adherence monitoring

• When CPAP may not be suitable or requires adjustment following specialist review

• Situations where symptoms such as chest pain, severe daytime sleepiness, or suspected heart disease require urgent assessment

We also discuss weight management, alcohol reduction, and positional therapy as part of comprehensive OSA management.

This episode complements our full clinical guide:

Using A CPAP May Lower Mortality Risk From Sleep Apnea-Related Heart Disease

https://www.mobidoctor.eu/blog/using-a-cpap-may-lower-mortality-risk-from-sleep-apnea-related-heart-disease

Mobi Doctor provides online medical consultations across Europe. Diagnosis and treatment decisions are based on individual assessment and established clinical criteria, and some cases require in-person specialist evaluation.